Effient

This approval was based on results from the TRITON-TIMI 38 clinical trial which compared Effient with Plavix (clopidogrel bisulfate tablets, from Bristol-Myers Squibb and Sanofi-Aventis) in reducing cardiovascular events in 13,608 acute coronary patients managed with PCI.

Sign In to MMM

SIGN IN WITH ONE OF YOUR SOCIAL ACCOUNTS

OR

Sign in with your MMM account

Keep me signed in Forgot your password?

Don't have one of these accounts?

Create an account for free »

Register for free with MMM

REGISTER FOR FREE WITH ONE OF YOUR SOCIAL ACCOUNTS

OR

REGISTER FOR FREE WITH A MMM ACCOUNT

Registration acknowledges the Terms and Conditions and Privacy Policy

Already have an account?

Log in now »

FORGET YOUR PASSWORD?

Enter your MMM registration email address to receive a new password.

NEW PASSWORD SENT

Already have an account?

Log in now »

ALMOST DONE

Almost Done

Please confirm the information BELOW before Signing In

By registering you agree with our Terms and Conditions and Privacy Policy.

« CANCEL AND GO BACK